Roche Cobas Liat System

Roche this week announced the launch of its cobas Liat System, a fast, compact molecular diagnostic platform designed for on-demand testing in physician clinics, pharmacies, and hospitals. The PCR-based system is fully automated and can generate test results in as little as 20 minutes, Roche said.

Roche also currently offers two tests on the system: cobas Influenza A/B and cobas Strep A. The Liat system and accompanying assays are both CE marked and cleared by the US Food and Drug Administration. Roche noted that the Liat System is not currently CLIA waived in the US and that testing sites outside the clinical laboratory are not available in all markets.